Phase 2 Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have signed and agreed to take part, and are able to follow the study procedures.
• You are 18 years of age or older.
• You have been diagnosed with B cell or T cell lymphoma (confirmed by a tissue sample) that has come back or stopped responding to treatment.
• You have already tried at least 2 different treatments for your lymphoma, and there are no other known treatments that are likely to help.
• Your lymphoma can be measured using standard medical imaging or assessment tools.
• Your general health and ability to carry out daily activities meets a certain minimum level (confirm with trial site).
• Your doctor expects you to live for more than 3 months.
• Your bone marrow, liver, kidneys, and blood clotting are all working well enough.
• Any side effects from previous cancer treatments have mostly cleared up before joining the trial (hair loss is an exception).

Who may not be able to join:

• You are pregnant, breastfeeding, or unwilling to use contraception during the study (applies to both women who could become pregnant and men).
• Your lymphoma has spread to the brain or spinal fluid.
• You have had another active cancer within the last 2 years.
• You have only had radiation or surgery to treat your lymphoma with no other areas of measurable disease, or you have had radiation or surgery within 2 weeks of starting the trial.
• You have received other cancer treatments, antibody therapies, or experimental treatments within 4 weeks before joining (or within a certain time based on the specific drug used).
• You have another serious illness that is not currently under control.
• You have a weakened immune system that puts you at higher risk of certain infections, or you have had a serious infection of that type in the last 12 months.
• You have an active or long-term hepatitis B infection, or an active hepatitis C infection.
• You have received a live vaccine within 30 days before joining the trial, or plan to during the study.
• Your heart's electrical activity shows a certain abnormality on an ECG test (confirm with trial site).
• You have received a COVID-19 vaccine within 3 weeks before starting the study drug.

Important: Always verify eligibility with the trial site directly before applying.